Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HYR-PB21 for postoperative analgesia after unilateral ankle fracture fixation
ChiCTR2400081845Phase 2Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Renji Hospital. Primary endpoint: Pain intensity score area under the curve from 0 to 72 hours. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400081845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081845.